Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
Open Access
- 6 October 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (1) , 225-237
Abstract
Purpose Population-based estimates of racial disparities in metastatic breast cancer are lacking. We quantified the contributions of demographic, socioeconomic, tumor, and metastatic characteristics to racial differences in metastatic breast cancer and characterized the most disproportional subgroup. Methods Patients diagnosed with metastatic breast cancer between 2010 and 2014 were identified using the Surveillance, Epidemiology, and End Results database. A multivariable Cox proportional hazards model was used to adjust each set of variables. The excess relative risk of cancer-specific and all-cause death in non-Hispanic black (NHB) versus non-Hispanic white women diagnosed with metastatic breast cancer was expressed as a percentage and was stratified by the age at diagnosis. Results We identified 13,066 female patients. NHB women exhibited substantially higher morbidity and mortality than women of other races/ethnicities. The greatest excess mortality risk for NHB women was observed in the young-onset group (18–49 years; hazard ratio: 1.57), followed by the middle-age group (50–64 years; hazard ratio: 1.42); the trend was not significant among the elderly group. Socioeconomic factors stably explained one-half of the excess risk, whereas the contribution of tumor characteristics obviously decreased with age (18–49 years, 40.7%; 50–64 years, 33.9%), and the metastatic pattern accounted for approximately one-tenth of the excess risk. Additionally, the disproportional death burden of NHB women persisted in less aggressive subgroups. Conclusions By providing a comprehensive assessment of racial differences in the incidence and outcomes of patients with metastatic breast cancer, we urge the implementation of targeted preventive efforts in both the public health and clinical arenas.Keywords
Funding Information
- National Natural Science Foundation of China (81572583, 8167260, 81602311)
- Ministry of Science and Technology of the People's Republic of China (MOST2016YFC0900300)
- Shanghai Committee of Science and Technology Funds (15410724000)
This publication has 45 references indexed in Scilit:
- Race/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United StatesJAMA Surgery, 2018
- Disparity in breast cancer mortality by age and geography in 10 racially diverse US citiesCancer Epidemiology, 2018
- Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood CharacteristicsJournal of Clinical Oncology, 2018
- Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013Journal of Clinical Oncology, 2018
- Breast cancer statistics, 2017, racial disparity in mortality by stateCA: A Cancer Journal for Clinicians, 2017
- African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stagesBreast Cancer Research and Treatment, 2017
- Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950–2014: Over Six Decades of Changing Patterns and Widening InequalitiesJournal of Environmental and Public Health, 2017
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenCA: A Cancer Journal for Clinicians, 2015
- Racial differences in outcomes for patients with metastatic breast cancer by disease subtypeBreast Cancer Research and Treatment, 2015
- A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for changeCA: A Cancer Journal for Clinicians, 2015